- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01095432
Partial Wave Spectroscopic Detection of Colon Cancer Risk (Brushings)
May 20, 2016 updated by: University of Chicago
The purpose of this study is to study samples of rectal mucosa (the moist lining of the rectum) using a new light scattering technology, called partial wave spectroscopy (PWS) in patients who will undergo a standard of care colonoscopy or a flexible sigmoidoscopy and have a history of ulcerative colitis (UC).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to study samples of rectal mucosa (the moist lining of the rectum) using a new light scattering technology, called partial wave spectroscopy (PWS)in patients who will undergo a colonoscopy or a flexible sigmoidoscopy and have a history of ulcerative colitis (UC).
PWS has been recently developed to allow scientists to learn about any changes to the cells that may indicate a risk of developing colon cancer.
We believe that the PWS test will more accurately detect the risk of colon cancer.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago, DCAM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects who are scheduled to undergo a standard of care flexible sigmoidoscopy or a colonoscopy and have a history of UC.
Description
Inclusion Criteria:
- Patient must be 18 years old or older.
- Patient is already scheduled for a standard of care colonoscopy or flexible sigmoidoscopy.
- Patient has not received chemotherapy.
- History of ulcerative colitis.
Exclusion Criteria:
- Patient is unable to give informed consent..
- Patient has received chemo or radiation therapy within the past 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Main Study Group
All subjects who are undergoing a standard of care colonoscopy for flexible sigmoidoscopy and have a history of UC and agree to participate will be in the main study group.
|
Partial wave spectroscopy (PWS)has been developed to allow scientists to learn about any changes to the cells that may indicate a risk of developing colon cancer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Study samples of rectal mucosa (the moist lining of the rectum) using PWS.
Time Frame: 1 year
|
Samples will be collected and then shipped to Northwestern University for analysis using PWS.
This is to assess accuracy of detecting the risk for colon cancer.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
March 24, 2010
First Submitted That Met QC Criteria
March 26, 2010
First Posted (Estimate)
March 30, 2010
Study Record Updates
Last Update Posted (Estimate)
May 23, 2016
Last Update Submitted That Met QC Criteria
May 20, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-066-B
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ulcerative Colitis
-
Odyssey TherapeuticsRecruitingUlcerative Colitis (UC) | UC - Ulcerative ColitisAustralia, Austria, Jordan, Poland, Ukraine, New Zealand, Canada, Czechia, Lithuania, Moldova
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; MRSU 938 - Research Center of Saint...Not yet recruitingPediatric Ulcerative Colitis in RemissionFrance
-
Ferring PharmaceuticalsCompletedActive Ulcerative Colitis | Remission of Ulcerative ColitisCanada
-
Rise Therapeutics LLCUniversity of Colorado, Denver; Mayo ClinicRecruitingUlcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic MildUnited States
-
Eli Lilly and CompanyRecruitingUlcerative Colitis, Active Severe | Ulcerative Colitis (UC) | Ulcerative Colitis, Active ModerateUnited States, China, Croatia, France, India, Japan, Israel, Taiwan, Brazil, Serbia, Greece, Hungary, Argentina, Italy, Poland, Czechia, Colombia, Lithuania, Latvia, Ukraine, South Africa, Portugal, Mexico, Canada, Slovakia, Turkey (Türkiye) and more
-
Palatin Technologies, IncActive, not recruitingUlcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute | UlcerativeUnited States
-
Theravance BiopharmaCompletedUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateUnited States, Georgia, Moldova, Republic of, Romania
-
InventisBio Co., LtdRecruitingModerately to Severely Active Ulcerative Colitis | UC - Ulcerative ColitisChina
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...CompletedDisease Activity | Ulcerative Colitis Flare | Remission of Ulcerative ColitisTurkey
-
Merck Sharp & Dohme LLCRecruitingUlcerative Colitis | Colitis UlcerativeUnited States
Clinical Trials on PWS Testing
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedObesity | Prader-Willi SyndromeUnited States
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...CompletedPrader-Willi Syndrome | Resistance Training
-
Blokhin's Russian Cancer Research CenterRecruitingGastric Cancer | Esophageal Cancer | Brain MetastasesRussia
-
The Hospital for Sick ChildrenCompleted
-
Democritus University of ThraceUniversity of ThessalyRecruitingRefractive Errors | Vision Disorders | Low VisionGreece
-
Hamilton Health Sciences CorporationCompleted
-
Democritus University of ThraceUniversity of ThessalyCompletedRefractive Errors | Presbyopia | Low Vision | Near Vision | ReadingGreece
-
Royal Devon and Exeter NHS Foundation TrustNot yet recruitingHIV Infections | Syphilis Infection | Hepatitis B and Hepatitis CUnited Kingdom
-
AstraZenecaNot yet recruitingNon-Small Cell Lung CancerChina
-
University of Alabama at BirminghamRecruitingDepression | Cognitive Impairment | Dementia | ADDUnited States